Additionally, overexpression of Grim19 has a therapeutic effect on cancer by reducing STAT3 signaling; in contrast, Grim19 deficiency accelerates tumor development by increasing the expression levels of STAT3-responsive genes [15, 16]. The gene discussed is STAT3; the disease is neoplasm.